Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model
- PMID: 26378060
- PMCID: PMC4741600
- DOI: 10.18632/oncotarget.5180
Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model
Abstract
Reduced dietary protein intake and intermittent fasting (IF) are both linked to healthy longevity in rodents, and are effective in inhibiting cancer growth. The molecular mechanisms underlying the beneficial effects of chronic protein restriction (PR) and IF are unclear, but may be mediated in part by a down-regulation of the IGF/mTOR pathway. In this study we compared the effects of PR and IF on tumor growth in a xenograft mouse model of breast cancer. We also investigated the effects of PR and IF on the mechanistic Target Of Rapamycin (mTOR) pathway, inhibition of which extends lifespan in model organisms including mice. The mTOR protein kinase is found in two distinct complexes, of which mTOR complex 1 (mTORC1) is responsive to acute treatment with amino acids in cell culture and in vivo. We found that both PR and IF inhibit tumor growth and mTORC1 phosphorylation in tumor xenografts. In somatic tissues, we found that PR, but not IF, selectively inhibits the activity of the amino acid sensitive mTORC1, while the activity of the second mTOR complex, mTORC2, was relatively unaffected by PR. In contrast, IF resulted in increased S6 phosphorylation in multiple metabolic tissues. Our work represents the first finding that PR may reduce mTORC1 activity in tumors and multiple somatic tissues, and suggest that PR may represent a highly translatable option for the treatment not only of cancer, but also other age-related diseases.
Keywords: aging; cancer; mTOR; mice; protein restriction.
Conflict of interest statement
None of the authors had conflicts of interest.
Figures
Similar articles
-
AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules.Mol Cancer Ther. 2015 Nov;14(11):2508-18. doi: 10.1158/1535-7163.MCT-15-0365. Epub 2015 Sep 10. Mol Cancer Ther. 2015. PMID: 26358751
-
CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization.Mol Cancer Ther. 2015 Jun;14(6):1295-305. doi: 10.1158/1535-7163.MCT-14-1052. Epub 2015 Apr 8. Mol Cancer Ther. 2015. PMID: 25855786
-
Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin.Lab Invest. 2013 Oct;93(10):1115-27. doi: 10.1038/labinvest.2013.98. Epub 2013 Aug 12. Lab Invest. 2013. PMID: 23938603
-
Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island.J Gerontol A Biol Sci Med Sci. 2016 Jul;71(7):841-9. doi: 10.1093/gerona/glw090. Epub 2016 May 21. J Gerontol A Biol Sci Med Sci. 2016. PMID: 27208895 Free PMC article. Review.
-
Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.Am J Physiol Heart Circ Physiol. 2015 Jul 1;309(1):H15-44. doi: 10.1152/ajpheart.00459.2014. Epub 2015 May 1. Am J Physiol Heart Circ Physiol. 2015. PMID: 25934099 Review.
Cited by
-
Effect of Lactational Low-Protein Diet on Skeletal Muscle during Adulthood and Ageing in Male and Female Mouse Offspring.Nutrients. 2024 Sep 1;16(17):2926. doi: 10.3390/nu16172926. Nutrients. 2024. PMID: 39275242 Free PMC article.
-
mTOR inhibitors for treatment of low-risk prostate cancer.Med Hypotheses. 2018 Aug;117:63-68. doi: 10.1016/j.mehy.2018.06.004. Epub 2018 Jun 5. Med Hypotheses. 2018. PMID: 30077200 Free PMC article.
-
Regulation of metabolic health by essential dietary amino acids.Mech Ageing Dev. 2019 Jan;177:186-200. doi: 10.1016/j.mad.2018.07.004. Epub 2018 Jul 22. Mech Ageing Dev. 2019. PMID: 30044947 Free PMC article. Review.
-
The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging.Front Aging. 2021 Aug 27;2:707372. doi: 10.3389/fragi.2021.707372. eCollection 2021. Front Aging. 2021. PMID: 35822019 Free PMC article. Review.
-
mTOR Complex 1 Content and Regulation Is Adapted to Animal Longevity.Int J Mol Sci. 2022 Aug 6;23(15):8747. doi: 10.3390/ijms23158747. Int J Mol Sci. 2022. PMID: 35955882 Free PMC article. Review.
References
-
- Solon-Biet SM, McMahon AC, Ballard JW, Ruohonen K, Wu LE, Cogger VC, Warren A, Huang X, Pichaud N, Melvin RG, Gokarn R, Khalil M, Turner N, Cooney GJ, Sinclair DA, Raubenheimer D, et al. The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell Metab. 2014;19:418–430. - PMC - PubMed
-
- Levine ME, Suarez JA, Brandhorst S, Balasubramanian P, Cheng CW, Madia F, Fontana L, Mirisola MG, Guevara-Aguirre J, Wan J, Passarino G, Kennedy BK, Wei M, Cohen P, Crimmins EM, Longo VD. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. 2014;19:407–417. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous